Bespoke Extracts (BSPK) Free Cash Flow Growth (1y) (2012 - 2025)
Bespoke Extracts (BSPK) Free Cash Flow Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 44.93% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 30.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30.78% |
| Jun 30, 2025 | -10.23% |
| Mar 31, 2025 | 24.95% |
| Dec 31, 2024 | -588.69% |
| Sep 30, 2024 | -504.37% |
| Jun 30, 2024 | 85.60% |
| Mar 31, 2024 | 53.06% |
| Dec 31, 2023 | 89.78% |
| Sep 30, 2023 | 101.12% |
| Jun 30, 2023 | -181.48% |
| Mar 31, 2023 | 8.78% |
| Nov 30, 2021 | 84.98% |
| May 31, 2021 | -545.14% |
| Feb 28, 2021 | -63.55% |
| Nov 30, 2020 | -57.88% |
| May 31, 2020 | 44.15% |
| Feb 29, 2020 | -28.13% |
| Nov 30, 2019 | -43.89% |
| Aug 31, 2019 | 58.06% |
| May 31, 2019 | 50.04% |